Yung-Luen Yu - Search Results

Year	Number of Results
2002	1
2005	1
2006	1
2008	2
2009	3
2010	6
2011	4
2012	7
2013	16
2014	12
2015	7
2016	3
2017	7
2018	6
2019	5
2020	8
2021	5
2022	2
2023	4
2024	0

1

The Function of the Mutant p53-R175H in Cancer.

Chiang YT, Chien YC, Lin YH, Wu HH, Lee DF, Yu YL. Chiang YT, et al. Among authors: yu yl. Cancers (Basel). 2021 Aug 13;13(16):4088. doi: 10.3390/cancers13164088. Cancers (Basel). 2021. PMID: 34439241 Free PMC article. Review.

2

The interconnected roles of TRIM21/Ro52 in systemic lupus erythematosus, primary Sjögren's syndrome, cancers, and cancer metabolism.

Hsu CH, Yu YL. Hsu CH, et al. Among authors: yu yl. Cancer Cell Int. 2023 Nov 22;23(1):289. doi: 10.1186/s12935-023-03143-x. Cancer Cell Int. 2023. PMID: 37993883 Free PMC article. Review.

3

Alpha-mangostin alleviate renal interstitial fibrosis via suppression of TGF-β1/Smad/ERK signaling axis in vitro and in vivo.

Juan YH, Yu YL, Tsai YP, Lee CC, Chen YS, Ting YH, Tsai JP, Hsieh YH. Juan YH, et al. Among authors: yu yl. Biochem Pharmacol. 2023 Dec;218:115935. doi: 10.1016/j.bcp.2023.115935. Epub 2023 Nov 19. Biochem Pharmacol. 2023. PMID: 37989414

4

The potential roles of EZH2 in regenerative medicine.

Chou RH, Chiu L, Yu YL, Shyu WC. Chou RH, et al. Among authors: yu yl. Cell Transplant. 2015;24(3):313-7. doi: 10.3727/096368915X686823. Epub 2015 Feb 2. Cell Transplant. 2015. PMID: 25647295 Free article. Review.

5

The potential therapeutic applications of olfactory ensheathing cells in regenerative medicine.

Chou RH, Lu CY; Wei-Lee; Fan JR, Yu YL, Shyu WC. Chou RH, et al. Among authors: yu yl. Cell Transplant. 2014;23(4-5):567-71. doi: 10.3727/096368914X678508. Cell Transplant. 2014. PMID: 24816451 Free article. Review.

6

EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis.

Wu CS, Chien YC, Yen CJ, Wu JY, Bai LY, Yu YL. Wu CS, et al. Among authors: yu yl. Cancer Cell Int. 2023 Sep 9;23(1):199. doi: 10.1186/s12935-023-03002-9. Cancer Cell Int. 2023. PMID: 37689710 Free PMC article.

7

Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling.

Yeh YW, Cheng CC, Yang ST, Tseng CF, Chang TY, Tsai SY, Fu E, Chiang CP, Liao LC, Tsai PW, Yu YL, Su JL. Yeh YW, et al. Among authors: yu yl. Oncotarget. 2017 Jan 17;8(3):5603-5618. doi: 10.18632/oncotarget.13629. Oncotarget. 2017. PMID: 27901498 Free PMC article. Review.

8

Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis.

Chang LC, Chiang SK, Chen SE, Yu YL, Chou RH, Chang WC. Chang LC, et al. Among authors: yu yl. Cancer Lett. 2018 Mar 1;416:124-137. doi: 10.1016/j.canlet.2017.12.025. Epub 2017 Dec 20. Cancer Lett. 2018. PMID: 29274359

9

Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology.

Liu LC, Chien YC, Wu GW, Hua CH, Tsai IC, Hung CC, Wu TK, Pan YR, Yang SF, Yu YL. Liu LC, et al. Among authors: yu yl. Int J Med Sci. 2022 May 29;19(6):1023-1028. doi: 10.7150/ijms.71931. eCollection 2022. Int J Med Sci. 2022. PMID: 35813302 Free PMC article.

10

Dietary components as epigenetic-regulating agents against cancer.

Chang LC, Yu YL. Chang LC, et al. Among authors: yu yl. Biomedicine (Taipei). 2016 Mar;6(1):2. doi: 10.7603/s40681-016-0002-8. Epub 2016 Feb 10. Biomedicine (Taipei). 2016. PMID: 26872811 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year